Gastrointestinal and Hepatic Disease in Systemic Lupus Erythematosus

被引：94

作者：

Brewer, Brian N. ^{[1
]}

Kamen, Diane L. ^{[2
]}

机构：

[1] Univ Georgia, Augusta Univ, Dept Internal Med, 108 Spear Rd, Athens, GA 30602 USA

[2] Med Univ South Carolina, Div Rheumatol & Immunol, 96 Jonathan Lucas St,Suite 916 E, Charleston, SC 29425 USA

来源：

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2018年 / 44卷 / 01期

关键词：

Lupus enteritis; Enteral vasculitis; Intestinal pseudo-obstruction; Protein-losing eriteropathy; CELIAC-DISEASE; MANIFESTATIONS; CLASSIFICATION; ANTINUCLEAR; VALIDATION; CRITERIA;

D O I：

10.1016/j.rdc.2017.09.011

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Gastrointestinal (GI) symptoms are common among patients with systemic lupus erythematosus (SLE), although only rarely are they caused by active organ system involvement from SLE itself. Rapid diagnosis and appropriate treatment of lupus enteritis and other GI manifestations of SLE are critical, because of the potential for organ and life-threatening complications. The 3 main variants of lupus enteritis are lupus mesenteric vasculitis, intestinal pseudoobstruction, and protein-losing enteropathy. These GI manifestations and others in patients with SLE are reviewed here.

引用

页码：165 / +

页数：13

共 31 条

[1] Lupus protein-losing enteropathy (LUPLE): A systematic review [J].

Al-Mogairen, Sultan M. .

RHEUMATOLOGY INTERNATIONAL, 2011, 31 (08) :995-1001

[2] Autoimmune gastrointestinal complications in patients with systemic lupus erythematosus: case series and literature review [J].

Alves, S. Custodio ;

Fasano, S. ;

Isenberg, D. A. .

LUPUS, 2016, 25 (14) :1509-1519

[3] Formation of Antinuclear and Double-strand DNA Antibodies and Frequency of Lupus-like Syndrome in Anti-TNF-α Antibody-treated Patients with Inflammatory Bowel Disease [J].

Beigel, Florian ;

Schnitzler, Fabian ;

Laubender, Ruediger Paul ;

Pfennig, Simone ;

Weidinger, Maria ;

Goeke, Burkhard ;

Seiderer, Julia ;

Ochsenkuehn, Thomas ;

Brand, Stephan .

INFLAMMATORY BOWEL DISEASES, 2011, 17 (01) :91-98

[4] Protein-Losing Enteropathy in Systemic Lupus Erythematosus: 12 Years Experience from a Chinese Academic Center [J].

Chen, Zhen ;

Li, Meng-Tao ;

Xu, Dong ;

Yang, Hong ;

Li, Jing ;

Zhao, Jiu-Liang ;

Zhang, Heng-Hui ;

Han, Shao-Mei ;

Xu, Tao ;

Zeng, Xiao-Feng .

PLOS ONE, 2014, 9 (12)

[5] All disease begins in the gut: Celiac disease co-existence with SLE [J].

Dahan, Shani ;

Shor, Dana Ben-Ami ;

Comaneshter, Doron ;

Tekes-Manova, Dorit ;

Shovman, Ora ;

Amital, Howard ;

Cohen, Arnon D. .

AUTOIMMUNITY REVIEWS, 2016, 15 (08) :848-853

[6] The effect of TNFalpha blockade on the antinuclear antibody profile in patients with chronic arthritis: biological and clinical implications [J].

De Rycke, L ;

Baeten, D ;

Kruithof, E ;

Van den Bosch, F ;

Veys, EM ;

De Keyser, F .

LUPUS, 2005, 14 (12) :931-937

[7] Celiac Disease and Autoimmunity: Review and Controversies [J].

Denham, Jolanda M. ;

Hill, Ivor D. .

CURRENT ALLERGY AND ASTHMA REPORTS, 2013, 13 (04) :347-353

[8] Gastrointestinal and Hepatic Manifestations of Systemic Lupus Erythematosus [J].

Ebert, Ellen C. ;

Hagspiel, Klaus D. .

JOURNAL OF CLINICAL GASTROENTEROLOGY, 2011, 45 (05) :436-441

[9]

Hellmann DB, 2016, CURRENT MED DIAGNOSI

[10] BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus [J].

Isenberg, DA ;

Rahman, A ;

Allen, E ;

Farewell, V ;

Akil, M ;

Bruce, IN ;

D'Cruz, D ;

Griffiths, B ;

Khamashta, M ;

Maddison, P ;

McHugh, N ;

Snaith, M ;

Teh, LS ;

Yee, CS ;

Zoma, A ;

Gordon, C .

RHEUMATOLOGY, 2005, 44 (07) :902-906

← 1 2 3 4 →